Department of Cardiology, Heart and Diabetes Centre North Rhine-Westphalia, Ruhr University Bochum, Bad Oeynhausen, Germany.
Sleep Breath. 2012 Sep;16(3):781-91. doi: 10.1007/s11325-011-0575-0. Epub 2011 Aug 28.
In patients with chronic heart failure, sleep-disordered breathing (SDB) is a common co-morbidity worsening prognosis. The aim of this study was to investigate whether assessment of specific symptoms can elucidate presence of SDB in these patients.
A prospective questionnaire scoring investigation on possible symptoms of sleep apnoea (nocturia, fatigue, daytime sleepiness, snoring, nocturnal sweating, witnessed apnoea's, nap) was conducted in 1,506 consecutive patients with stable chronic heart failure (LVEF ≤45%, NYHA ≥2). Afterwards, polysomnography or polygraphy, capillary blood gas analysis, echocardiography, and cardiopulmonary exercise testing were performed.
Adjusted for all significant covariates, snoring (p < 0.01) was the only symptom independently associated with OSA, while witnessed apnoeas (p = 0.02) and fatigue (p = 0.03) independently predicted for CSR. As additional parameters, higher BMI (threshold 26.6; p < 0.01) and higher pCO(2) (threshold 37.6 mmHg; p < 0.01) were independently associated with OSA and male gender (p < 0.001) and lower pCO(2) (threshold 35.0 mmHg; p < 0.001) with CSA. Cumulative questionnaire score results did not sufficiently (OSA--sensitivity 0.40, specificity 0.74; CSA--sensitivity 0.57, specificity 0.59) predict SDB.
Although in chronic heart failure patients with either OSA or CSA specific symptoms are apparent, combining clinical data, demographic data, and capillary blood gas analysis results appears favourable to determine the presence of SDB.
在慢性心力衰竭患者中,睡眠呼吸障碍(SDB)是一种常见的合并症,会使预后恶化。本研究旨在探讨评估特定症状是否可以阐明这些患者 SDB 的存在。
对 1506 例稳定的慢性心力衰竭患者(LVEF ≤45%,NYHA ≥2)进行前瞻性问卷调查评分,以评估可能的睡眠呼吸暂停症状(夜尿、疲劳、白天嗜睡、打鼾、夜间出汗、目击呼吸暂停、小睡)。之后进行多导睡眠图或多导睡眠描记术、毛细血管血气分析、超声心动图和心肺运动试验。
调整所有显著协变量后,打鼾(p < 0.01)是与 OSA 独立相关的唯一症状,而目击呼吸暂停(p = 0.02)和疲劳(p = 0.03)独立预测 CSR。作为附加参数,更高的 BMI(阈值 26.6;p < 0.01)和更高的 pCO(2)(阈值 37.6 mmHg;p < 0.01)与 OSA 相关,而男性性别(p < 0.001)和较低的 pCO(2)(阈值 35.0 mmHg;p < 0.001)与 CSA 相关。累积问卷评分结果不能充分(OSA-灵敏度 0.40,特异性 0.74;CSA-灵敏度 0.57,特异性 0.59)预测 SDB。
尽管在患有 OSA 或 CSA 的慢性心力衰竭患者中存在特定症状,但结合临床数据、人口统计学数据和毛细血管血气分析结果似乎有利于确定 SDB 的存在。